Comments

WAVE Life Sciences Analyst Ratings

WVENASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$16.20

-0.14-0.86%

Last update: Dec 18, 9:41 AM

Overview News Earnings Options

Analyst Ratings

Insider Trades Short Interest Stock Report

Consensus Rating¹

Buy

Highest Price Target¹

$50.00

Lowest Price Target¹

$10.00

Consensus Price Target¹

$26.36

WAVE Life Sciences Analyst Ratings and Price Targets | NASDAQ:WVE | Benzinga

WAVE Life Sciences Ltd has a consensus price target of $26.36 based on the ratings of 22 analysts. The high is $50 issued by Truist Securities on December 15, 2025. The low is $10 issued by Cantor Fitzgerald on April 29, 2025. The 3 most-recent analyst ratings were released by Oppenheimer, Truist Securities, and B. Riley Securities on December 16, 2025, December 15, 2025, and December 12, 2025, respectively. With an average price target of $39.67 between Oppenheimer, Truist Securities, and B. Riley Securities, there's an implied 144.86% upside for WAVE Life Sciences Ltd from these most-recent analyst ratings.

Analyst Trends and Forecast

Aug

Sep

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Analyst Firms Making Recommendations¹

Oppenheimer

Truist Securities

B. Riley Securities

Wedbush

Citigroup

¹calculated from analyst ratings

Analyst Ratings for WAVE Life Sciences

					Get Alert
Dec 16, 2025	97.53%	Cheng LiOppenheimer 43%	24 32	Previous Outperform Current Outperform	Get Alert
Dec 15, 2025	208.64%	Joon LeeTruist Securities 80%	36 50	Previous Buy Current Buy	Get Alert
Dec 12, 2025	128.4%	Madison El-SaadiB. Riley Securities 63%	19 37	Previous Buy Current Buy	Get Alert
Dec 12, 2025	103.7%	Yun ZhongWedbush 64%	20 33	Previous Outperform Current Outperform	Get Alert
Dec 9, 2025	85.19%	Samantha SemenkowCitigroup 47%	16 30	Previous Buy Current Buy	Get Alert
Dec 9, 2025	146.91%	Whitney IjemCanaccord Genuity 73%	19 40	Previous Buy Current Buy	Get Alert
Dec 9, 2025	79.01%	Benjamin BurnettWells Fargo 58%	16 29	Previous Overweight Current Overweight	Get Alert
Dec 9, 2025	109.88%	Steve SeedhouseCantor Fitzgerald 65%	12 34	Previous Overweight Current Overweight	Get Alert
Dec 9, 2025	190.12%	Bill MaughanClear Street 36%	22 47	Previous Buy Current Buy	Get Alert
Dec 9, 2025	66.67%	Luca IssiRBC Capital 64%	9 27	Previous Sector Perform Current Outperform	Get Alert
Nov 11, 2025	23.46%	Yun ZhongWedbush 64%	18 20	Previous Outperform Current Outperform	Get Alert
Nov 11, 2025	-1.23%	Benjamin BurnettWells Fargo 58%	16 18	Previous Overweight Current Overweight	Get Alert
Oct 15, 2025	35.8%	Bill MaughanClear Street 36%	22	Previous Initiates Current Buy	Get Alert
Sep 4, 2025	11.11%	Tiago FauthWells Fargo 57%	18 21	Previous Overweight Current Overweight	Get Alert
Sep 3, 2025	35.8%	Andrew S. FeinHC Wainwright & Co. 81%	22 22	Previous Buy Current Buy	Get Alert
Aug 4, 2025	17.28%	Whitney IjemCanaccord Genuity 73%	19	Previous Initiates Current Buy	Get Alert
Jul 31, 2025	29.63%	Tiago FauthWells Fargo 57%	21 24	Previous Overweight Current Overweight	Get Alert
Jul 28, 2025	48.15%	Cheng LiOppenheimer 43%	24	Previous Initiates Current Outperform	Get Alert
Jul 16, 2025	-1.23%	Samantha SemenkowCitigroup 47%	16	Previous Initiates Current Buy	Get Alert
Jun 23, 2025	11.11%	Yun ZhongWedbush 64%	18 18	Previous Outperform Current Outperform	Get Alert
Jun 11, 2025	-13.58%	Michael FreemanRaymond James 72%	14	Previous Current Outperform	Get Alert
Apr 29, 2025	-38.27%	Steven SeedhouseCantor Fitzgerald 56%	10	Previous Initiates Current Overweight	Get Alert
Mar 26, 2025	35.8%	Andrew FeinHC Wainwright & Co. 76%	22 22	Previous Buy Current Buy	Get Alert
Mar 5, 2025	35.8%	Andrew FeinHC Wainwright & Co. 76%	22 22	Previous Buy Current Buy	Get Alert
Feb 25, 2025	60.49%	Roger SongJefferies 64%	26	Previous Initiates Current Buy	Get Alert
Nov 21, 2024	35.8%	Salim SyedMizuho 50%	19 22	Previous Outperform Current Outperform	Get Alert
Nov 13, 2024	35.8%	Andrew FeinHC Wainwright & Co. 76%	22 22	Previous Buy Current Buy	Get Alert
Nov 12, 2024	122.22%	Joon LeeTruist Securities 80%	17 36	Previous Buy Current Buy	Get Alert
Nov 4, 2024	35.8%	Madison El-SaadiB. Riley Securities 63%	19 22	Previous Buy Current Buy	Get Alert
Oct 31, 2024	35.8%	Andrew FeinHC Wainwright & Co. 76%	22 22	Previous Buy Current Buy	Get Alert
Oct 21, 2024	-7.41%	Luca IssiRBC Capital 64%	7 15	Previous Sector Perform Current Sector Perform	Get Alert
Oct 17, 2024	4.94%	Eric JosephJP Morgan 47%	13 17	Previous Overweight Current Overweight	Get Alert
Oct 17, 2024	35.8%	Andrew FeinHC Wainwright & Co. 76%	22 22	Previous Buy Current Buy	Get Alert
Oct 16, 2024	35.8%	Steven SeedhouseRaymond James 56%	13 22	Previous Outperform Current Strong Buy	Get Alert
Oct 16, 2024	35.8%	Tiago FauthWells Fargo 57%	11 22	Previous Overweight Current Overweight	Get Alert
Oct 16, 2024	35.8%	Mani ForooharLeerink Partners 56%	20 22	Previous Outperform Current Outperform	Get Alert
Oct 4, 2024	-56.79%	Luca IssiRBC Capital 64%	5 7	Previous Sector Perform Current Sector Perform	Get Alert
Oct 3, 2024	17.28%	Madison El-SaadiB. Riley Securities 63%	11 19	Previous Buy Current Buy	Get Alert
Sep 27, 2024	-19.75%	Eric JosephJP Morgan 47%	10 13	Previous Overweight Current Overweight	Get Alert
Sep 25, 2024	-1.23%	Catherine NovackJones Trading 51%	12 16	Previous Buy Current Buy	Get Alert
Sep 25, 2024	35.8%	Andrew FeinHC Wainwright & Co. 76%	15 22	Previous Buy Current Buy	Get Alert
Sep 19, 2024	-32.1%	Madison El-SaadiB. Riley Securities 63%	11	Previous Initiates Current Buy	Get Alert
Sep 9, 2024	-38.27%	—	10	Previous Initiates Current Overweight	Get Alert
Aug 9, 2024	-25.93%	Catherine NovackJones Trading 51%	12	Previous Initiates Current Buy	Get Alert
Jun 26, 2024	-7.41%	Andrew FeinHC Wainwright & Co. 76%	15 15	Previous Buy Current Buy	Get Alert
Jun 25, 2024	17.28%	Salim SyedMizuho 50%	19 19	Previous Outperform Current Outperform	Get Alert
May 15, 2024	-32.1%	Tiago FauthWells Fargo 57%	11	Previous Initiates Current Overweight	Get Alert
Apr 1, 2024	4.94%	Joon LeeTruist Securities 80%	17 17	Previous Buy Current Buy	Get Alert
Mar 12, 2024	17.28%	Salim SyedMizuho 50%	10 19	Previous Buy Current Buy	Get Alert
Mar 7, 2024	-69.14%	Luca IssiRBC Capital 64%	5 5	Previous Sector Perform Current Sector Perform	Get Alert
Mar 7, 2024	-7.41%	Andrew FeinHC Wainwright & Co. 76%	8 15	Previous Buy Current Buy	Get Alert
Dec 19, 2023	-25.93%	Mani ForooharLeerink Partners 56%	12	Previous Market Perform Current Outperform	Get Alert
Aug 4, 2023	-50.62%	Andrew FeinHC Wainwright & Co. 76%	8	Previous Buy Current Buy	Get Alert
Jul 5, 2023	-56.79%	Steven SeedhouseRaymond James 56%	7	Previous Initiates Current Outperform	Get Alert
Jun 23, 2023	4.94%	Joon LeeTruist Securities 80%	17	Previous Buy Current Buy	Get Alert
May 24, 2023	-38.27%	Salim SyedMizuho 50%	10 13	Previous Buy Current Buy	Get Alert
May 24, 2023	-50.62%	Andrew FeinHC Wainwright & Co. 76%	8	Previous Buy Current Buy	Get Alert
May 4, 2023	-69.14%	Luca IssiRBC Capital 64%	5	Previous Current Sector Perform	Get Alert
Apr 14, 2023	-19.75%	Salim SyedMizuho 50%	13	Previous Current Buy	Get Alert
Mar 23, 2023	-50.62%	Andrew FeinHC Wainwright & Co. 76%	8	Previous Current Buy	Get Alert

FAQ

What is the target price for WAVE Life Sciences (WVE) stock?

The latest price target for WAVE Life Sciences (NASDAQ:WVE) was reported by Oppenheimer on December 16, 2025. The analyst firm set a price target for $32.00 expecting WVE to rise to within 12 months (a possible 97.53% upside). 25 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for WAVE Life Sciences (WVE)?

The latest analyst rating for WAVE Life Sciences (NASDAQ:WVE) was provided by Oppenheimer, and WAVE Life Sciences maintained their outperform rating.

When was the last upgrade for WAVE Life Sciences (WVE)?

The last upgrade for WAVE Life Sciences Ltd happened on December 9, 2025 when RBC Capital raised their price target to $27. RBC Capital previously had a sector perform for WAVE Life Sciences Ltd.

When was the last downgrade for WAVE Life Sciences (WVE)?

There is no last downgrade for WAVE Life Sciences.

When is the next analyst rating going to be posted or updated for WAVE Life Sciences (WVE)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of WAVE Life Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for WAVE Life Sciences was filed on December 16, 2025 so you should expect the next rating to be made available sometime around December 16, 2026.

Is the Analyst Rating WAVE Life Sciences (WVE) correct?

While ratings are subjective and will change, the latest WAVE Life Sciences (WVE) rating was a maintained with a price target of $24.00 to $32.00. The current price WAVE Life Sciences (WVE) is trading at is $16.20, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.